CHREBP Suppresses Gastric Cancer Progression via the Cyclin D1-RB-E2F1 Pathway

Investigators found carbohydrate response element binding protein (CHREBP) downregulation in gastric cancer (GC) tissues, and CHREBP was determined to be an independent diagnostic marker of GC.